HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell by Boullé, Mikaël et al.
RESEARCH ARTICLE
HIV Cell-to-Cell Spread Results in Earlier
Onset of Viral Gene Expression by Multiple
Infections per Cell
Mikae¨l Boulle´1,2,3,4, Thorsten G. Mu¨ller1, Sabrina Da¨hling1, Yashica Ganga1,
Laurelle Jackson1,3, Deeqa Mahamed1,3, Lance Oom1,3, Gila Lustig1, Richard A. Neher5,
Alex Sigal1,2,3*
1 KwaZulu-Natal Research Institute for TB-HIV (K-RITH), Durban, South Africa, 2 Max Planck Institute for
Infection Biology, Berlin, Germany, 3 University of KwaZulu-Natal, Durban, South Africa, 4 Charite´ Medical
School, Berlin, Germany, 5 Max Planck Institute for Developmental Biology, Tu¨bingen, Germany
* alex.sigal@k-rith.org, sigal@mpiib-berlin.mpg.de
Abstract
Cell-to-cell spread of HIV, a directed mode of viral transmission, has been observed to be
more rapid than cell-free infection. However, a mechanism for earlier onset of viral gene
expression in cell-to-cell spread was previously uncharacterized. Here we used time-lapse
microscopy combined with automated image analysis to quantify the timing of the onset of
HIV gene expression in a fluorescent reporter cell line, as well as single cell staining for
infection over time in primary cells. We compared cell-to-cell spread of HIV to cell-free
infection, and limited both types of transmission to a two-hour window to minimize differ-
ences due to virus transit time to the cell. The mean time to detectable onset of viral gene
expression in cell-to-cell spread was accelerated by 19% in the reporter cell line and by
35% in peripheral blood mononuclear cells relative to cell-free HIV infection. Neither factors
secreted by infected cells, nor contact with infected cells in the absence of transmission,
detectably changed onset. We recapitulated the earlier onset by infecting with multiple cell-
free viruses per cell. Surprisingly, the acceleration in onset of viral gene expression was not
explained by cooperativity between infecting virions. Instead, more rapid onset was consis-
tent with a model where the fastest expressing virus out of the infecting virus pool sets the
time for infection independently of the other co-infecting viruses.
Author Summary
How quickly infection occurs should be an important determinant of viral fitness, but
mechanisms which could accelerate the onset of viral gene expression were previously
undefined. In this work we use time-lapse microscopy to quantify the timing of the HIV
viral cycle and show that onset of viral gene expression can be substantially accelerated.
This occurs during cell-to-cell spread of HIV, a mode of directed viral infection where
multiple virions are transmitted between cells. Surprisingly, we found that neither coop-
erativity between infecting viruses, nor trans-acting factors from already infected cells,
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influence the timing of infection. Rather, we show experimentally that a more rapid onset
of infection is explained by a first-past-the-postmechanism, where the fastest expressing
virus out of the infecting virus pool sets the time for the onset of viral gene expression of
an individual cell independently of other infections of the same cell. Fast onset of viral
gene expression in cell-to-cell spread may play an important role in seeding the HIV reser-
voir, which rapidly makes infection irreversible.
Introduction
Cell-to-cell spread of HIV is a mechanism of viral transmission whereby interaction between
an infected donor cell and an infectable target cell leads to the directed transmission of virions
to the target cell. Such interactions can occur between donor and target cells by various mecha-
nisms [1–12], all of which involve the directed delivery of virions very close to the target cell,
minimizing the distance over which virions need to diffuse and the consequent loss of virions
en route [1–9, 11–24]. Because of the resulting high efficiencyof viral delivery, target cells in
cell-to-cell spread are exposed to multiple virions per cell both in in vitro infections and in vivo
[17, 18, 25–31]. Multiple infections per cell decrease the sensitivity of cell-to-cell spread to anti-
retroviral drugs [17, 25, 27, 32, 33] and neutralizing antibodies [18, 34–36], and can overcome
low infectivity and cellular restriction factors [37], since they increase the chances that at least
one of the transmitted virions will successfully infect the cell despite inhibitors or unfavorable
infection conditions [27, 38]. Because the source of insensitivity to inhibitors in cell-to-cell
spread of HIV derives frommultiple infections per cell, it is expected that sufficiently high
inhibitor concentrations, or inhibitors more adept at suppressing multiple infections, could
overcome this barrier [32, 33]. Conversely, cell-to-cell spread would offer a window of oppor-
tunity for HIV to evolve resistance to antiviral inhibitors [35].
As well as decreasing sensitivity to inhibitors, cell-to-cell spread of HIV was observed to be
more rapid than cell-free infection [2, 13, 39–41]. One explanation may be fusion between
donor and target cells. Fusion is insufficient for infection, as nucleic acids cannot directly infect
a cell by translocating to the uninfected target cell [22]. However, the target cell would be
scored as infected if a viral gene product or marker is used for detection, as fused cells share
their protein pools and the marker would translocate to the target from the donor cell whether
or not infection of the target cell took place. If fusion is excluded, acceleration of the viral cycle
may be the result of several mechanisms: Shorter distance for the virus to transit before reach-
ing a target cell, faster virus entry, faster pre- or post-integration dynamics due to cooperativity,
and faster dynamics due to trans-acting factors secreted by the donor cells. Cooperativity
would be expected to play a role in accelerating the virus cycle due to the Tat positive feedback
loop [42–44], where Tat expressed from one provirus would trigger the transcript elongation
of another provirus. Since the Tat protein can diffuse in and out of cells [43], such acceleration
can also be potentially mediated in trans by the presence of nearby infected cells. Other HIV
proteins, such as Nef, may also modify the physiology of yet uninfected cells upon cell-to-cell
contact [45].
Another mechanism which can contribute to the acceleration of the viral cycle is probabilis-
tic: since time to productive infection varies between virions due to integration site and sto-
chastic gene expression [42, 44, 46, 47], cell-to-cell spread, which leads to multiple infections
per cell, could increase the probability that at least one of the infecting viruses would have
rapid infection dynamics.
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Here we determined the timing of cell-to-cell spread and cell-free infection in a short infec-
tion time window, thereby limiting the role that the transit time to the target cell plays in infec-
tion timing. Despite this, we observed that cell-to-cell spread of HIV led to significantly earlier
onset of viral gene expression. Surprisingly, we did not find evidence that factors secreted by
donor cells, infected donor cell contact with target cells in the absence of transmission, or coop-
erativity between virions caused the earlier gene expression onset. We were able to replicate
earlier onset in viral protein expression by increasing the multiplicity of infectionwith cell-free
virus. This explains the observed rapid onset of viral gene expression of cell-to-cell spread by a
mechanism where the fastest virus to be expressed sets the time of infection independently of
other infections of the same cell.
Results
Cell-to-cell spread leads to earlier onset of HIV gene expression
In this study, we used the timing of the detectable onset of viral gene expression as a measure
of the rate of the viral cycle.We used several ways to detect HIV gene expression, as summa-
rized in S1 Table. Virus used for infectionwas produced from a molecular clone of the NL4-3
HIV strain to minimize any sequence differences between infecting virions. To compare the
onset of cell-free infection to cell-to-cell spread, we infected target cells with either cell-free
virus obtained from the filtered supernatant of virus producing cells, or by coculture with
infected donor cells. In coculture, infection consists of a mix of cell-to-cell spread of HIV and
cell-free infection.Hence, any observeddifference between coculture and cell-free infection
would be an underestimate of the difference between cell-to-cell spread and cell-free infection.
In order to quantify the onset of coculture versus cell-free infection by time-lapse micros-
copy, we imaged infection in the RevCEMcell line [48]. This cell line contains a GFP reporter
that is responsive to the HIV splicing regulator protein Rev and hence reflects the timing of
late HIV proteins [43, 49–51]. In order to efficiently detect infection, we subcloned the cell line
to produce the reporter clone E7. This increased the maximum percentage of GFP positive
cells from approximately 10% in the parental line to 70% in E7 (Fig 1A, left column). To enable
the automated determination of the number of infected target cells (S1 Fig), we further stably
expressedmCherry in these cells and derived the mCherry labelled G2 clone (Fig 1A, middle
column). To exclude donor-target cell fusions, we labelled donor cells with the vital stain Cell-
Trace Far Red (CTFR, Fig 1A, right column). CTFR and mCherry double positive cells were
excluded from the analysis. In the absence of fusion exclusion, coculture infection showed a
baseline from the earliest time points, which may not be real infection (S2 Fig).
We imaged infection over two days (S1 Movie). We used automated image analysis to deter-
mine the number of GFP+/mCherry+/CTFR- cells over the total number of mCherry+/CTFR-
cells in each field of view at each frame of the movie (Fig 1B). In this experiment and the other
time-lapse experiments performed in this study, we did not track individual cells, but rather
measured the number of target cells with detectable viral gene expression at each time-point.
We limited infection to the first two hours by washing away cell-free virus after that time win-
dow, and inhibiting additional infection cycles by addition of the protease inhibitor atazanavir
(ATV), which has been described to effectively inhibit cell-to-cell transmission [33]. We
imaged infection after washing and ATV addition. The protease inhibitor was used at a con-
centration that blocked over 99% of coculture infections (S3A Fig). This window for infection
limited the time that the virus could transit to the target cell to no more than two hours in both
coculture and cell-free infection.We calibrated the input of cell-free virus and infected cells so
that the frequency of infected target cells after 48 hours was similar between the infection
modes and did not saturate the available target cells (S4 Fig).
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Fig 1. HIV cell-to-cell spread leads to earlier onset of HIV gene expression. (A) Infection system. Left
column shows uninfected (top plot) or HIV infected (bottom plot) E7 donor cells. Middle column shows
uninfected (top plot) or HIV infected (bottom plot) G2 target cells. Right column shows the labelling of donor
cells with CTFR for donor-target fusion exclusion. Numbers are percent of cells in the associated quadrant.
(B) Time-lapse images from one field of view (FOV). At each time point post-infection, cells were imaged for
GFP, mCherry, and CTFR fluorescence. Bar is 15μM. (C) Quantified timing of coculture (red) versus cell-free
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We quantified the fraction of infected cells over time and observed that both cell-free and
coculture infection resulted in a variable time to Rev activity in individual infected cells, con-
sistent with previous results showing heterogeneity in the length of the HIV replication cycle
in cell-free infection [52]. In both infectionmodes, no Rev activity was detected before
approximately 20 hours, corresponding to a period of intracellular delay [53–55]. On average,
coculture infection showed more rapid HIV gene expression relative to cell-free infection (Fig
1C). We derived the mean and standard deviation for the timing of coculture and cell-free
infections by parametrizing the number of infected cells over time with a best fit Gamma dis-
tribution, since Gamma distributions are a standard model for the timing of multi-step pro-
cesses [56]. We obtained a time to detectable per cell Rev activity in coculture infection of 28
±5.0 hours (mean±std). In contrast, mean time to per cell Rev activity in cell-free infection
was 34.5±6.1 hours. This constituted an acceleration of 19% in the mean time to Rev activity
in coculture infection. The difference between the two means was significant (p = 9x10-4,
bootstrap).
Secreted factors and contact with infected cells in the absence of
transmission do not accelerate HIV gene expression
We investigated the role of secreted factors acting in trans in the earlier onset of HIV gene
expression by coculture with infected donor cells. To isolate the contribution of factors acting
in trans, we separated infected donors from targets by a transwell membrane permeable to cell-
free virus and soluble factors. We obtained no acceleration of time to detectable GFP expres-
sion using transwell infection (Fig 2A).
We considered the possibility that factors acting in trans may only operate over very short
distances or that direct contact between donor and target cells, unrelated to viral transmission,
may be required for an earlier onset of HIV gene expression. To test this, we took advantage of
the fact that our reporter cell line could only be infected with HIV which uses the CXCR4 co-
receptor. We therefore infected cells using the cell-free route with our CXCR4 tropic strain
(NL4-3) in the presence of coculturedCD4+ cells infected with CCR5 tropic HIV (NL-AD8).
This CCR5 tropic strain is identical to NL4-3, except for the Env protein, which is specific for
the CCR5 co-receptor. We verified that NL-AD8 infected CD4+ cells could not infect the G2
target cells by coculture (S5 Fig). We did not observe a more rapid onset of HIV gene expres-
sion of cell-free infection coculturedwith cells infected with the CCR5 tropic HIV compared to
cell-free infection in the absence of these cells (Fig 2B), indicating that trans-acting factors are
unlikely to induce an earlier onset of viral gene expression.
Multiple infections per cell result in earlier onset of HIV gene expression
We asked whether the higher force of infection in cell-to-cell spread, manifesting as multiple
infections per target cell, leads to earlier onset of HIV gene expression. We therefore used con-
centrated cell-free virus to mimic the higher infection levels per cell observed in cell-to-cell
spread. We used the highly infection permissiveMT4 cell line [27] to enable infection at a mul-
tiplicity greater than 1 within a two-hour infectionwindow. As a reporter for infection, we
used the NL4-3YFP strain of HIV [57] which substitutes YFP for the HIV early gene Nef.
Therefore, YFP expression reflects the timing of HIV early genes (S1 Table). We infectedMT4
(blue) infection. Each point represents the frequency of infected target cells normalized to the mean
frequency in the last three hours of the movie. Shown are means and standard errors over 25 FOVs. One of
five independent experiments.
doi:10.1371/journal.ppat.1005964.g001
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cells with NL4-3YFP cell-free virus (S2 Movie) at increasingmultiplicities of infection (MOI)
per target cell, starting at an MOI of 0.1 infectious units per cell and up to an MOI of 4. After
two hours, we removed the residual virus by washing and added sufficient ATV to prevent
additional infections from coculture (S3B Fig).
Fig 2. Acceleration of viral gene expression in coculture infection is not due to factors acting in
trans. (A) Frequency of infected G2 target cells in coculture (red), cell-free (blue), coculture separated by
transwell (green) or cell-free infection across the transwell (yellow). Shown are means and standard errors
over 15 FOVs. One of three independent experiments. (B) Frequency of infected G2 target cells in coculture
(red) versus cell-free infection in the absence (blue) or presence (green) of CD4+ primary T cells infected with
NL-AD8 CCR5 tropic HIV which cannot infect G2 cells. Shown are means and standard errors over 25 FOVs.
One of three independent experiments. For both experiments, frequencies of infected cells were normalized
by mean infected target cell frequency in the last 3 hours of the movie. Fusion events leading to false positive
target cells were excluded with CTFR.
doi:10.1371/journal.ppat.1005964.g002
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We observed a more rapid onset of YFP expression with increasingMOI, acceleratingmean
expression time from 27.5±6.1 hours at an MOI of 0.1, which results almost exclusively in
infections with one virus, to 22.6±5.5 hours at an MOI of 4 (Fig 3A). This acceleration in onset
relative to the 0.1 MOI infectionwas significant (p = 1.7x10-3 for MOI = 0.5, p<10−4 for
MOI = 2 and MOI = 4 using bootstrap).
We asked whether this earlier onset was mediated by cooperativity: pre- or post-integration
interactions between virions that would lead to faster HIV gene expression. For this, we com-
pared MT4 cells infected with NL4-3YFP alone to MT4 cells co-infectedwith NL4-3YFP and
the unlabeledNL4-3 strain of HIV. The unlabeledHIV infectionwas at high multiplicity
(MOI = 8) to ensure that the majority of cells infected with the YFP reporter HIV were also co-
infected with the unlabeledHIV. If cooperativity has a role in the more rapid onset of viral
gene expression, the unlabeled virus should accelerate the expression of labelled virus to the
threshold of detection.However, we observed that co-infection did not lead to a more rapid
onset of YFP expression (Fig 3B).
MT4 cells are known to be infected with HTLV-I [58] and hence any lack of cooperativity
due to co-infectionmay be the result of saturating cooperativity with the endogenous virus.
We therefore proceeded to investigate cooperativity in the onset of HIV gene expression
between co-infecting viruses in primary CD4+ T cells. To investigate cooperativity in this sys-
tem, we co-infected cells by the cell-free route with HIV expressing YFP and HIV expressing
CFP. We detected the number of infected cells by flow cytometry at 6 hour intervals.We
obtained CFP and YFP singly infected cells, as well as low but significant numbers of double
infected cells (S6 Fig). We did not observe differences in timing of the onset of viral gene
expression between singly infected and the CFP/YFP co-infected cells, indicating that co-
infecting viruses did not show cooperativity in the onset of viral gene expression in primary
CD4+ T cells and confirming our results in MT4 cells.
Since cooperativity between virions could not account for the earlier onset of HIV gene
expression, we asked whethermultiple infections per cell accelerated onset of gene expression
by a first-past-the-postmechanism, where the earliest virus to express sets the time of infection
(Fig 4A). This mechanism operates if: 1) Each integrated virus has a stochastically set time to
viral protein expression. 2) Infections proceed independently. 3) A single expressed virion is
sufficient to make use of target cell resources so that the target cell becomes infectious [26].
We reasoned that if a cell is infected by n>1 virions, the virion that first completes the repli-
cation cycle sets the time to infection. If each infection is independent, the distribution of the
time to infection given n virions per cell is:
pt; n  n pt1   Qtn 1: 1
Here p(t) is the distribution of the time to viral gene expression given a single virion per cell
approximated by a Gamma distribution, and Q(t) is the corresponding cumulative distribution.
In an infectionwith an average MOIm, the cells will be infected with a number of virions
which is Poisson distributed aroundm and can be modelled by the average of Eq 1 over differ-
ent n with Poisson weights (excluding n = 0). The distribution of the time to viral gene expres-
sion atm is then given by:
rt;m 
e m
1   e m
Sn1
mn
n!
pt; n; 2
where the pre-factor normalizes the distribution.We determined the shape and scale parame-
ters of p(t) by jointly fitting the time series data for the multiple MOI infections to Eq 2. The
model fits the data well for MOI 0.1, 0.5, 2, 4 with only the two parameters of the Gamma
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Fig 3. Earlier onset of HIV gene expression by multiple infections per cell. (A) Timing of HIV gene
expression onset as a function of multiplicity of infection (MOI) per cell. MT4 cells were infected with HIV
strain NL4-3YFP at an MOI of 0.1 (blue), 0.5 (green), 2 (red) and 4 (purple). Shown are means and standard
errors over 15 FOVs. One of three independent experiments. (B) Measurement of cooperativity between
infecting viruses. Infection as detected using YFP expression when cells were infected with NL4-3YFP alone
at MOI of 0.3 (blue), or with YFP at the same MOI co-infected with unlabeled NL4-3 at an MOI of 8 (red).
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distribution, indicating that our model of independent stochastic infections can explain the
acceleration at highMOI (Fig 4B).
To determine the effectiveMOI for coculture infections, we fitted the time course data to Eq
2 using the shape and scale parameters of the Gamma distribution determined by a fit to the
cell-free data, approximating n = 1 for cell-free infections (Fig 4C). We obtained that the accel-
eration of viral gene expression with coculture was predicted by an effectiveMOI of 4.6 per
cell.
Coculture infection leads to earlier onset of HIV gene expression in
primary human cells
To examine whether the earlier onset of HIV gene expression observed in the cell line also
occurs in primary cells, we used coculture with autologous infected donor cells or cell-free
virus to infect peripheral bloodmononuclear cells (PBMCs) derived from healthy donors. As
with the cell lines, donor cells were separated from target cells by labelling them with a vital
stain. The fraction of infected target cells at different times post-infectionwas quantified by
detection of the viral p24 protein, made as part of the HIV Gag polyprotein, using flow cytome-
try (Fig 5A). Virus was washed away after 2 hours in both cell-free and coculture infections,
and ATV added to prevent additional infection cycles. ATV was used at a concentration suffi-
cient to inhibit more than 99% of coculture infections (S3C Fig). Coculture dramatically accel-
erated the onset of HIV gene expression as measured by the detection of the HIV Gag protein
relative to cell-free infection in primary human cells from 34.2±9.1 hours to 22.1±9.3 hours
(mean±std). This constituted a decrease of 35% in the mean time to detectableHIV Gag
expression (Fig 5B). Based on the cell-free distribution, the best-fit MOI per cell in coculture
infection to recapitulate the difference in viral expression onset was 5.0 (Fig 5B, dashed red
line).
PBMCs contain monocytes and other cells which may complicate interpretation of these
results. To investigate whether T cell to T cell transmission was sufficient for the faster onset of
viral gene expression, we repeated the experiment with purifiedCD4+ T cells (Fig 5B Inset and
S7 Fig). We confirmed that cell-to-cell transmission between autologous T cells resulted in a
more rapid onset of viral gene expression relative to cell-free infection.
We next proceeded to compare our predicted number of infections per cell using the timing
of the onset of viral gene expression to that obtained by a secondmethod.We have previously
developed an approach to predict the number of infections per cell in cell-to-cell spread based
on the reduced sensitivity to antiretroviral drugs relative to cell-free infection [27]. We there-
fore performed the PBMC infection in the presence of the integrase inhibitor raltegravir
(RAL). As in the timing experiments, we used a 2-hour infectionwindow. Coculture infection
decreased sensitivity to RAL (Fig 6), consistent with our previous work and that of others
showing that cell-to-cell spread decreases sensitivity to HIV inhibitors. For PBMC infection,
IC50 of cell-free infectionwas 1.9nM and the maximum concentration of RAL used (60nM)
decreased infection 12.2-fold. In contrast, IC50 of infectionwas 10nM and infectionwas
Shown are means and standard errors over 25 FOVs. One of three independent experiments. For both
experiments, frequencies of infected cells were normalized by mean infected cell frequency in the last 3
hours of the movie. (C) Measurement of cooperativity in onset of HIV gene expression in CD4+ T cell
infection. Cells were infected with NL4-3YFP and NL4-3CFP, and single (CFP or YFP) and double infected
(CFP+YFP) cells were quantified by flow cytometry at the indicated time points. The frequency of CFP, YFP,
and CFP+YFP positive cells normalized to the frequency at 48 hours post-infection is indicated by blue,
green, and red points respectively. Shown are mean and standard errors of quadruplicate measurements of
one representative experiment out of three, using three different blood donors.
doi:10.1371/journal.ppat.1005964.g003
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Fig 4. Modelling faster onset of HIV gene expression by multiple infections per cell. (A) Proposed
probabilistic mechanism for the more rapid onset of HIV gene expression. (B) Simulation of cell-free infection
times at different MOI by random draws from a Gamma distribution parametrizing the best fit cell-free
infection times of single virion infections. Circles are experimental data from Fig 3A, dashed lines represent
the simulation results for MOI of 0.1 (blue), 0.5 (green), 2 (red), and 4 (purple). Fitted means±std of infection
times were 26.4±5.2, 25.2±5.1, 22.7±4.8, and 21.9±4.9 hours. (C) Fit of coculture versus cell-free infection.
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reduced 2.6-fold at the same RAL concentration when transmission was by coculture. Reduced
RAL sensitivity of coculture infectionwas also confirmedwith transmission between purified
autologous CD4+ T cells using a 2-hour infectionwindow (Fig 6 Inset). In this case, 60nM RAL
reduced cell-free infection by 33.3-fold. In contrast, coculture infectionwas reduced 3.6-fold.
The best-fit MOI per cell needed to account for the reduced sensitivity of PBMC coculture
infection to RAL was 4.8, which was similar to the number of virions predicted using infection
timing under the same infection conditions.
Discussion
We have observed faster onset of viral gene expression in coculture infection containing cell-
to-cell spread of HIV relative to cell-freeHIV infection. The earlier onset of viral gene expres-
sion in coculture was lost when target cells were separated from donor cells by a transwell
membrane. A faster virus cycle in cell-to-cell spread relative to the non-directed, cell-freemode
of infection has been previously observeddirectly [2, 13, 41] and inferred throughmodelling of
infection dynamics [39, 40]. Here we used time-lapse microscopy of HIV infection to directly
quantify and investigate the mechanism behind the faster onset of viral gene expression. We
minimized possible differences between cell-to-cell spread and cell-free infection in the extra-
cellular transit time from donor to target cell by limiting the time window of transmission to 2
hours. We have also minimized any contribution of virus sequence to different viral gene
expression dynamics by using viruses with identical sequences derived from a molecular clone.
Hence, variability in gene expression is a result of the interaction of the virus with the host cell.
After exclusion of donor-target cell fusions, we found a minimum time for early viral protein
expression in both infectionmodes, corresponding to a period of intracellular delay indicative
of true infection [53–55]. We found that we could recapitulate the faster onset of viral gene
expression by increasing theMOI of cell-free virus, and that there was no evidence for coopera-
tivity or interference between co-infecting viruses. There was also no evidence for trans-accel-
eration of HIV gene expression onset from the surrounding infected cells.
Previous studies on cell-to-cell spread have concentrated on understanding the mechanisms
by which cell-to-cell transmission occurs, and such mechanisms may lead to a faster onset of
the expression of viral genes in the infected target cell in addition to making the infectionmore
efficient. For example, it has been reported that the infected donor cell rapidly polarizes to the
site of contact with the target cell [20] and that the subsequent transmission to the target cell
occurs quickly [4, 18, 59, 60], though viral membrane fusion has been reported to be slower in
cell-to-cell spread relative to cell-free infection [16]. Hence, a faster onset of HIV gene expres-
sion in cell-to-cell spread may be strictly mechanistic, due to more rapid entry of the virus. In
this case, it would be expected that increasing cell-freeMOI would not lead to faster onset, as
increasing the MOI does not change the attachment and entry route. Since our data shows that
cell-freeMOI does control the onset of HIV gene expression, mechanistic factors such as more
rapid entry in cell-to-cell spread are unlikely to play a major role.
Given multiple infections of the same cell in cell-to-cell spread, we would expect three possi-
bilities of how co-infecting viruses could interact at the level of viral gene expression [61]. The
first would be synergistic/cooperative interactions, where expression of one virus amplifies the
expression of a co-infecting virus. The second would be no interaction, and the third would be
that co-infecting virusesmay compete for cellular resources and hence expression of one virus
Circles are experimental data from Fig 1C, dashed lines represent the simulation results. Means±std for the
fits were 28.0±5.0 hours for coculture and 34.5±6.2 hours for cell-free infections. Best fit MOI for the
coculture infection was 4.6.
doi:10.1371/journal.ppat.1005964.g004
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Fig 5. Earlier onset of HIV gene expression in PBMCs by coculture infection. (A) Gating strategy for detectably
infected target cell frequency. Donors were labelled with CTFR and infection was assayed by flow cytometry following p24
staining for HIV Gag. Top row is coculture infection, bottom row is cell-free infection. Percent of infected targets in the
population (bottom right quadrant) shown in red, and values for other subpopulations in black. (B) Timing of coculture (red)
versus cell-free (blue) infection. Shown are means and standard errors of duplicates from one of three experiments with
different blood donors. Frequencies of infected target cells were normalized by infected target cell frequency at 50 hours
post infection. Means±std of best fit Gamma distributions were 22.1±9.3 hours for coculture and 34.2±9.1 hours for cell-free
infection. Best fit MOI for the coculture infection was 5.0 (dashed red line). Inset: Infection of purified CD4+ T cells by cell-
free HIV or autologous infected CD4+ T cells. Shown are mean and standard errors of duplicates of the frequencies of
infected target cells normalized to the frequency of infected target cells at 48 hours post-infection. One of three
experiments, each performed on purified CD4+ T cells from a different individual. Timing differences between cell-free and
coculture in CD4+ T cells were statistically significant at 12, 24 and 36 hours post-infection (p<0.01, two-tailed unpaired t-
test corrected for multiple comparisons using the Sidak-Bonferroni method).
doi:10.1371/journal.ppat.1005964.g005
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would interfere with the expression of co-infecting viruses. For example, comparing 10 co-
infecting viruses to 10 infections identical in everyway except occurring in 10 different cells,
cooperativity would lead to the cell with 10 co-infecting viruses to show more rapid onset of
viral gene expression relative to any one of the 10 single infections. No interaction between
viruses would lead to the onset in the cell with 10 co-infecting viruses to be as fast as the fastest
cell among the 10 singly infected cells, what we term a first-past-the-postmechanism. Interfer-
ence or antagonism would lead to the cell with 10 co-infecting viruses to show a slower onset
of viral gene expression than the fastest cell among the 10 singly infected cells, and possibly
slower than the other singly infected cells.
Interactions between co-infecting viral genomes in HIV and other viruses have been exten-
sively documented. For example, co-infecting viruses share post-integration components by a
process known as complementation [62–66]. Hence, we would have predicted that there is at
least some cooperativity in viral gene expression between co-infecting viruses as a result of the
Tat positive feedback loop, as intracellular Tat concentration should increase with the number
of expressed proviruses [42–44]. This mechanism of cooperativity would be expected to mani-
fest as faster onset of viral gene expression since the delay to build up Tat levels by basal tran-
scription should be reduced [44]. However, no detectable differences in the timing of the onset
of HIV gene expression upon co-infection of YFP-HIV with unlabeled virus and no detectable
differences when primary CD4+ cells were co-infectedwith two viruses argues against the pres-
ence of cooperativity at the onset of gene expression. Likewise, no interference was observed.
Fig 6. Decreased sensitivity of coculture HIV spread to RAL predicts multiple infections per cell.
Sensitivity of coculture (red) and cell-free (blue) infection to the integrase inhibitor raltegravir (RAL) in
PBMCs. Points are means and standard errors of duplicates from one of three experiments with different
blood donors. Transmission index (Tx) was calculated as the number of infected target cells with RAL divided
by the number of infected target cells without RAL. Blue dashed line represents parametrization of the cell-
free infection response to RAL in terms of IC50 (1.9 nM) and hill coefficient (0.7). Red dashed line represents
the fit of coculture infection using the decreased sensitivity to RAL (Materials and methods). An effective MOI
of 4.8 is predicted for coculture infection. Inset: Sensitivity of primary CD4+ T cell infection to RAL. Points are
Tx means and standard errors of duplicates from one of three experiments with different blood donors. The
drug sensitivity differences in CD4+ T cells between cell-free and coculture was statistically significant
(p < 0.001, two-tailed unpaired t-test).
doi:10.1371/journal.ppat.1005964.g006
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Instead, we found that the mechanismmost consistent with the faster onset of viral gene
expression was that multiple infections per cell in coculture infection resulted in a pool of
viruses which express viral genes at different times post-infection.The virus with the fastest
onset of gene expression from this pool sets the start time for the generation of viral compo-
nents by the infected cell.
We note that the lack of cooperativity as detected at the onset of HIV gene expression does
not mean that co-infecting viruses do not interact, and interactions may occur later in the virus
cycle. For example, interference may be expected to occur close to the time of peak virus pro-
duction, where co-infecting viruses could compete for limited cellular resources to assemble
virions [26, 67]. Such effects would influence the number of virions produced, but not the
onset of gene expression as measured here.
We compared the predicted number of infections per cell based on the timing of the viral
cycle to that predicted by the decreased sensitivity of coculture infection to an antiretroviral
drug. The MOI per cell in PBMC coculture infectionwas predicted by timing to be 5.0 infec-
tious viruses. This was similar to the predictedMOI based on the degree of insensitivity of
PBMC coculture infection to the antiretroviral RAL (MOI = 4.8). Interestingly, the drug insen-
sitivity of cell-to-cell spread to RAL was maintained despite keeping infection to one virus
cycle using ATV. This indicates that the faster virus cycle of cell-to-cell spread is not necessary
for drug insensitivity. However, a faster virus cycle may contribute to replication in the face of
drug by amplifying an expanding infection.
Assuming that faster viral gene expression leads to more rapid viral dynamics, a more rapid
onset of the viral cycle may confer a fitness advantage of rapid initial expansion, or transmis-
sion where the turnover rate of infected cells is high [2, 68]. Reasons for high turnover may
include targeting of infected cells by cytotoxic T lymphocytes [69, 70], or a limited infection
window due to bystander killing of target cells [71–74], all operating in environments such as
lymph nodes where cell-to-cell infection is likely to occur [29, 31, 71, 73]. In exponential
expansion at the R0 observedduring primaryHIV infection (~8, [75]), decreasing the infection
cycle time by one quarter can lead to a 2 order of magnitude increase in the number of infected
cells over several weeks. A large reservoir would be a barrier to a prolonged period of treatment
interruption without rebound or to a permanent cure [76–81]. Thus, a faster viral cycle may
seed a larger HIV reservoir, which would be more difficult to eliminate. However, if the most
rapid virus cycle rate gives the highest fitness advantage, then cooperativity in gene expression
would have been expected to evolve. Yet it does not seem to occur, perhaps indicating draw-
backs to cooperativity such as more rapid cytotoxicity, or decreased ability of the virus to enter
a quiescent state [82–85].
Materials and Methods
Ethical statement
Bloodwas obtained from adult healthy volunteers after written informed consent (University
of KwaZulu-Natal Institutional ReviewBoard approval BE022/13).
Inhibitors, viruses and cells
The following reagents were obtained through the AIDS Research and Reference Reagent Pro-
gram, National Institute of Allergy and Infectious Diseases, National Institutes of Health: the
antiretroviral drugs ATV and RAL; Rev-CEMcells from Y. Wu and J. Marsh [48]; MT-4 cells
from D. Richman [58]; HIV expression plasmid pNL4-3 fromM.Martin [86] and pNL-AD8
from E. Freed [87]. The NL4-3YFPmolecular clone was a gift from D. Levy [57]. Cell-free
viruses were produced by transfection of HEK293 cells (ATCC) with molecular clones using
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TransIT-LT1 (Mirus) or Fugene HD (Roche) transfection reagents. Supernatant containing
released virus was harvested after two days of incubation and filtered through a 0.45μm filter
(Corning). The number of virus genomes in viral stocks was determined using the RealTime
HIV-1 viral load test (Abbott Diagnostics). To produce the E7 clone, RevCEMcells were sub-
cloned at single cell density and screened for the fraction of GFP expressing cells upon HIV
infection using microscopy. To produce the G2 clone, E7 cells were stably infected with the
mCherry gene under the control of the EF-1α promoter on a pHAGE2 based lentiviral vector
(gift from A. Balazs), subcloned, and screened for clones with>99%mCherry positive cells.
Similarly, the MT4-mCherry cell line was created by infectingMT4-cells with the pHAGE2
lentiviral vector expressing mCherry. PBMCs were isolated by density gradient centrifugation
using Histopaque 1077 (Sigma-Aldrich).CD4+ cells were positively selected using CD4
Microbeads loaded onto MACS separation columns according to manufacturer’s instructions
(Miltenyi Biotec). Culture and experiments were performed in complete RPMI 1640 medium
supplemented with L-Glutamine, sodiumpyruvate, HEPES, non-essential amino acids
(Lonza), and 10% heat-inactivated FBS (Hyclone). Primary cells were additionally supple-
mented with IL-2 at 5ng/ml (PeproTech). PBMCs and CD4+ T cells were activated at 2106
per ml density for one (donor cells) or three days (target cells) with PHA at 10μg/ml (Sigma-
Aldrich).
Infection
For infection of RevCEMclones, 5x105 cells/ml E7 reporters were infected with 2x108 NL4-3
viral copies/ml (20ng p24 equivalent [88]) and used as infected donor cells. Infected and unin-
fected donors were incubated for two days, then stained with CellTrace Far Red (CTFR,
Thermo Fisher Scientific) at 1μM and washed according to manufacturer’s instructions.G2
reporters at 5x105 cells/ml were either coculturedwith 1:20 infected donor cells, or 1:20 unin-
fected donor cells and 109 NL4-3 viral copies/ml cell free virus. For RevCEMcoculture experi-
ments with cells infected with CCR5 tropic HIV, activated CD4+ cells at a concentration of 106
cells/ml were infected with 2x108 NL-AD8 viral copies per ml. Infected and uninfectedCD4+
cells were incubated for two days. After two days, CD4+ cells were stained with CTFR as above.
G2 cells were then infected with 109 copies/ml cell-freeNL4-3, and coculturedwith either
infected or uninfectedCD4+ cells, equal in number to the number of NL4-3 infected E7 cells
added to the coculture positive control. For MT4 infections, cells were infected at a density
of 5x105 cells/ml with 1.2x108 (MOI = 0.1) to 5x109 (MOI = 4) viral copies per ml of NL4-
3YFP. For cooperativity experiments,MT4 cells were infected with 4x108 NL4-3YFP alone
(MOI = 0.3) or co-infectedwith 4x108 copies of NL4-3YFP (MOI = 0.3) and 5x109 copies NL4-
3 (MOI = 8). For PBMC infections, one day activated cells at a concentration of 106 cells/ml
were used as donors and infected with 2x108 NL4-3 viral copies per ml. Donor cells were incu-
bated for two days, and were separated from target cells by labelling them with CTFR or with
carboxyfluorescein succinimidyl ester at 1μM (CFSE, Thermo Fisher Scientific) vital stain.
CTFR or CFSE positive cells were excluded from the analysis, being either donors or donor-tar-
get fusions. Three day activated PBMC target cells at 106 cells/ml were then infected with either
1:10 infected donor cells, or with 1:10 uninfected donor cells and 5x108 copies of cell-freeNL4-
3. All cell-free and coculture infections of target cells were washed twice in medium after a two
hour incubation with cell-free virus or infected donors, then resuspended in fresh growth
mediumwith ATV. In the RAL sensitivity experiments, RAL was pre-incubated with target
cells 4 hours before infection. Experiments comparing drug sensitivity and viral expression
onset of co-culture and cell-free infections in primary CD4+ T cells were performed as with
PBMCs. For experiments examining cooperativity in CD4+ T cells, infectionwith NL4-3YFP
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and NL4-3CFP was performed by adding 5x108 cell-free virions of each strain per 106 cells.
CD4+ T cells were washed twice 2 hours post-infection and ATV was added as for PBMCs.
Staining and flow cytometry
PBMCs and CD4+ cells infected with NL4-3wt or NL-AD8 were strained with anti-p24 FITC-
conjugated or PE-conjugated antibody (KC57, BeckmanCoulter) using the Cytofix/Cytoperm
and the Perm/Wash buffers (BD Biosciences) according to manufacturer’s instructions. Cells
were acquired with a FACSAriaIII or FACSCaliber machine (BD Biosciences) using 488 and
640nm laser lines. A minimum of 105 cells per sample were acquired. Results were analyzed
with FlowJo 10.0.8 software. For CFP/YFP co-infection experiments, cells were acquired with a
FACSAriaIII using the 405nm laser line for CFP, and 488nm laser line for YFP.
Time-lapse microscopy
Cell density was reduced to 7x104 cells/ml and cells were attached to ploy-l-lysine (Sigma-
Aldrich) coated 6-well optical plates (MatTek). Cell-free and coculture infections were imaged
in tandem using a Metamorph-controlled Nikon TiE motorizedmicroscopewith a 20x, 0.75
NA phase objective in a biosafety level 3 facility. Excitation sources were 488 (GFP, YFP), 561
(mCherry), or 640 nm (CTFR) laser lines and emission was detected through a Semrock
Brightline quad band 440–40 /521-21/607-34/700-45 nm filter. Images were captured using an
888 EMCCD camera (Andor). Temperature (37°C), humidity and CO2 (5%) were controlled
using an environmental chamber (OKO Labs). Fields of view were captured every 30 minutes
and a minimum of 1000 target cells were acquired per condition. Threshold for detection of
the onset of HIV gene expression was set so that no positive cells were detected in the unin-
fected control. Cells with above threshold expression were scored as positive.
Transwell assay
Cells were either infected by coculture in the lower compartment of a 6-well transwell plate
with 0.4 μm pores (Costar) or separated across the membrane. To maintain a similar fraction
of infected cells, 10-fold more donors were used when infectionwas across the membrane rela-
tive to coculture. Cell-free infectionwas performed in the lower compartment or across the
membrane. After six-hour incubation, infectionwas washed, ATV added, and cells transferred
to optical plates for imaging, keeping the donors in their initial compartments but not in the
focal plane.
Image analysis
Movies were analyzed using custom code developedwith the Matlab R2014a Image Analysis
Toolbox. Images in the mCherry channel were thresholded to obtain images, and the imfind-
circle function used to detect round objects within the cell radius range. Cell centers were
found. GFP and CTFR signals underwent the same binary thresholding. The number of
mCherry positive 16 pixel2 squares around the cell centers, negative for fluorescence in the
CTFR channel and positive for fluorescence in the GFP channel, was used as the number of
infected target cells. YFP signal in MT4 mCherry cells was analyzed in the same way except no
CTFR stain was used, as infection was by cell-free virus.
Normalization to distribution tail
For time-lapse experiments, data was normalized to compare infection between experimental
conditions that had a similar, but not exactly equal number of infected cells. Normalization
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was by the average of the fraction of infected target cells during the last three hours to accu-
rately capture the maximum infection level at the end of the viral cycle. Normalization by the
maximum number of infected target cells was found to be noisy since it was sensitive to outlier
values in the data.
Modeling
Fitting of time-lapse data was done using a custom Python script using the Powell minimiza-
tion algorithm from scipy (S1 Script). For drug sensitivity modelling, cell-free infection in the
presence of increasing RAL concentrations was parametrized using the relation
d  1  
1
1  
IC50
D 
h ; 3
where d denotes the decrease in the experimentally determined fraction of infected cells relative
to no drug,D is the drug concentration, and IC50, and h are the open parameters for the fit
[89]. The number of infectious viruses per target cell (m) delivered in coculture infectionwas
determined by fitting
Tx 
Idrug
I
 1   e md=1   e m; 4
where Tx is the experimentally determined number of coculture infected cells in the presence
of different RAL concentrations normalized by the number of infected cells in the absence of
RAL [27], and d is determined for each drug concentration by Eq 3. Script is provided (S2
Script).
Supporting Information
S1 Fig. Image analysis strategy. The mCherry fluorescent signal was thresholded to a binary
mask and the number of circular objects in the image was detected using the Matlab Image
Analysis Toolbox. From top to bottom, in processing order: 1) all cells, phase contrast; 2)
mCherry signal from target cells; 3) binary thresholdedmCherry signal; 4) mCherry cell cen-
ters (kernels); 5) phase, mCherry signal, and kernel overlay. Bar is 15μM. GFP and CTFR sig-
nals underwent the same binary thresholding. The number of mCherry positive 16 pixel2
squares around the cell centers, negative for fluorescence in the CTFR channel and positive for
fluorescence in the GFP channel, was used as the number of infected target cells.
(TIF)
S2 Fig. Fusion exclusion is necessaryto accurately quantify infection at early time-points.
Lack of fusion exclusion results in a baseline of coculture infection at the earliest time points.
Data as in Fig 1C, except CTFR was not used to exclude donor-target fusion events.
(TIF)
S3 Fig. Inhibition of additional infection cycles using ATV in cell lines and primary cells.
Data is from coculture infections, and transmission index (Tx) is calculated as the number of
target cells infected in the presence of ATV divided by the number of target cells infected in the
absence of ATV. (A) RevCEM clones. (B) MT-4 cells. (C) PBMCs. Shown are means and stan-
dard errors of duplicates. One of three independent experiments for each cell type.
(TIF)
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S4 Fig. Raw percent of infected target cells in coculture and cell-free infection.Data as in
Fig 1C, except no normalization was applied.
(TIF)
S5 Fig. NL-AD8 infected donor PBMCs infect PBMCs but are unable to infect G2 targets.
Left two bars show infection of PBMCs by PBMC donors infected with NL-AD8 (red) or NL4-
3 (blue). Right two bars show the percent of G2 infected after coculture with the same number
of PBMC donors infectedwith either NL-AD8 or NL4-3. Shown are means and standard errors
of duplicates. One of three independent experiments.
(TIF)
S6 Fig. Gating strategy to detect CFP, YFP, and CFP/YFP co-infectedprimaryCD4+ T
cells. Percent infected cells shown for CFP (top left quadrant), YFP (bottom right quadrant),
and CFP/YFP co-infected (top right).
(TIF)
S7 Fig. Gating strategy to detect infected target cell frequency in primaryCD4+ T cell infec-
tion.Donors were labelled with CFSE and infection was assayed by flow cytometry following
p24 staining for HIV Gag. Top row is coculture infection, bottom row is cell-free infection. Per-
cent of infected targets in the population (bottom right quadrant) shown in red, and values for
other subpopulations in black.
(TIF)
S1 Table. Markers for infection.
(TIF)
S1 Movie. Time-lapsemicroscopy of RevCEM clone infection.Cells were imaged for GFP,
mCherry, and CTFR fluorescence using time-lapse microscopy. Time is hours:minutes post-
infection, bar is 20μM. Infected GFP+, mCherry+ target cells appear as yellow, CTFR+ donor
cells as blue. ATV was added after wash and before the start of the movie to bracket infection
to a 2-hour time window. Hence few new transmissions of viable virus occurredduring the
movie.
(MP4)
S2 Movie. Time-lapsemicroscopy of MT4 cell infection by cell-freeHIV. Cells were imaged
for YFP and mCherry, fluorescence using time-lapse microscopy. Time is hours:minutes post-
infection, bar is 20μM. Infected YFP+, mCherry+ cells appear as yellow. ATV was added after
wash and before the start of the movie to bracket infection to a 2-hour time window.
(MP4)
S1 Script. Global fitting of time-lapse data using Gammadistribution. Python.
(PY)
S2 Script. Drug sensitivitymodel.Matlab.
(M)
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